|
|
|
|
Vol. 16, Issue 8, 3821-3831, August 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, and c-Jun NH2-terminal Kinase to Induce Apoptosis


* Department of Oncology and Pathology, Cancer Centrum Karolinska, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden;
Ludwig Institute for Cancer Research, Biomedical Center, S-752 37 Uppsala, Sweden;
Division of Toxicology, Institute of Environmental Medicine, Karolinska Institute, S-171 77 Stockholm, Sweden; and
Childhood Cancer Research Unit, Astrid Lindgrens Children's Hospital, Karolinska Hospital, SE-171 76 Stockholm, Sweden
Submitted October 4, 2004;
Revised May 11, 2005;
Accepted May 18, 2005
Monitoring Editor: John Cleveland
Here, we identified caspase-2, protein kinase C (PKC)
Address correspondence to: Dan Grandér (Dan.Grander{at}cck.ki.se).
This article has been cited by other articles:
, and c-Jun NH2-terminal kinase (JNK) as key components of the doxorubicin-induced apoptotic cascade. Using cells stably transfected with an antisense construct for caspase-2 (AS2) as well as a chemical caspase-2 inhibitor, we demonstrate that caspase-2 is required in doxorubicin-induced apoptosis. We also identified PKC
as a novel caspase-2 substrate. PKC
was cleaved/activated in a caspase-2dependent manner after doxorubicin treatment both in cells and in vitro. PKC
is furthermore required for efficient doxorubicin-induced apoptosis because its chemical inhibition as well as adenoviral expression of a kinase dead (KD) mutant of PKC
severely attenuated doxorubicin-induced apoptosis. Furthermore, PKC
and JNK inhibition show that PKC
lies upstream of JNK in doxorubicin-induced death. Jnk-deficient mouse embryo fibroblasts (MEFs) were highly resistant to doxorubicin compared with wild type (WT), as were WT Jurkat cells treated with SP600125
and JNK do not synergize and do not function in doxorubicin-treated AS2 cells. Caspase-2, PKC
, and JNK were furthermore implicated in doxorubicin-induced apoptosis of primary acute lymphoblastic leukemia blasts. The data thus support a sequential model involving caspase-2, PKC
, and JNK signaling in response to doxorubicin, leading to the activation of Bak and execution of apoptosis.
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E04-10-0862) on May 25, 2005.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
![]()
![]()

![]()
![]()
![]()
T. Panaretakis, L. Hjortsberg, K. P. Tamm, A.-C. Bjorklund, B. Joseph, and D. Grander
Interferon {alpha} Induces Nucleus-independent Apoptosis by Activating Extracellular Signal-regulated Kinase 1/2 and c-Jun NH2-Terminal Kinase Downstream of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin
Mol. Biol. Cell,
January 1, 2008;
19(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
R. Gomel, C. Xiang, S. Finniss, H. K. Lee, W. Lu, H. Okhrimenko, and C. Brodie
The Localization of Protein Kinase C{delta} in Different Subcellular Sites Affects Its Proapoptotic and Antiapoptotic Functions and the Activation of Distinct Downstream Signaling Pathways
Mol. Cancer Res.,
June 1, 2007;
5(6):
627 - 639.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
C. G. Pham, C. Bubici, F. Zazzeroni, J. R. Knabb, S. Papa, C. Kuntzen, and G. Franzoso
Upregulation of Twist-1 by NF-{kappa}B Blocks Cytotoxicity Induced by Chemotherapeutic Drugs
Mol. Cell. Biol.,
June 1, 2007;
27(11):
3920 - 3935.
[Abstract]
[Full Text]
[PDF]
![]()
Copyright © 2005 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.